European Parliament backs new genomic techniques regulation

The European Parliament has given final approval to an EU regulation on new genomic techniques, moving the bloc a major step toward a lighter regime for many genome-edited crops.

The vote on June 17, 2026, is the most significant parliamentary endorsement yet for a framework that would treat most genome-edited plants more like conventional crops than like genetically modified organisms under the EU's existing rules.

Supporters say the change could speed up the development of plant varieties better able to withstand drought, heat and other climate stress. Critics say the move goes too far, too fast, and could strengthen corporate control over seeds through patents.

What the text changes

Under the approved rules, many genome-edited plants would no longer face the full GMO-style treatment that has long applied in the EU.

The reporting behind the vote says those crops would not require environmental or health risk assessments, coexistence measures with non-NGT crops such as organic agriculture, or monitoring of possible genetic leakage into wild flora.

Seed bags would still need to indicate whether a variety is NGT or not for farmers' information. That label requirement is narrower than the traceability rules some lawmakers wanted for final consumer products.

A shift from 2024

The June 2026 approval also marks a clear shift from the European Parliament's earlier position in February 2024, when MEPs backed a different approach to new genomic techniques.

At that time, parliamentarians supported traceability and non-patentability, showing how divided the issue has been even before the final vote.

The new result suggests the political center of gravity in Parliament has moved. Le Monde reported that support stretched from the centrist Renew group to the far right.

The dispute over patents and transparency

Patentability remained one of the most contentious issues in the debate.

Greens and Social Democrats pushed amendments that would have required traceability for final consumer products and banned patentability. Those amendments were rejected.

Critics argue that without those safeguards, the new framework could make it easier for larger seed and agrochemical companies to consolidate control over breeding rights and licensing.

Supporters counter that patents can be part of the investment case for innovation and that the EU should not leave breeders without clear routes to market.

Scientific claims remain split

The politics of the file overlap with a scientific dispute over whether genome-edited plants should face the same kind of case-by-case checks used for some other technologies.

Le Monde reported that France's ANSES had recommended case-by-case risk assessments for NGT varieties before market authorization, while the European Food Safety Authority concluded such assessments were unnecessary.

That difference has helped shape the broader argument. Supporters of the lighter regime say the rules should reflect the nature of the changes made to the plant, not just the breeding method used.

Opponents say the safety case for broad deregulation is not proven and should not be assumed away.

Why supporters want change

The Parliament's backers frame the regulation as an agricultural tool as much as a legal one.

They argue that new genomic techniques could help breeders produce crops that cope better with drought, heat and other pressures linked to climate change.

They also see the current EU framework as too slow and too rigid for a technology that may be able to deliver targeted changes without the same level of risk associated with older genetic modification methods.

Who is watching

The debate has drawn in lawmakers, regulators, seed companies, organic farming groups and public research bodies.

The European Parliament's position matters because it sets the direction of the file, but the broader dispute is still likely to continue as the regulation moves through the next legislative stage with the Council and formal EU adoption steps.

The issue is especially sensitive for organic and non-NGT farmers, who want to know how the new framework will affect coexistence rules, market monitoring and supply-chain oversight.

What comes next

The next questions are practical as well as political.

Observers will be watching the final legal text, the implementation timetable and any review-clause language on patent concentration.

Those details will determine how much the new regime changes day-to-day breeding and marketing rules, and how far lawmakers are willing to go in loosening oversight for genome-edited crops.

For now, the Parliament's approval marks a major step toward a new EU framework for NGT plants, but not the end of the fight over safety, transparency and control of the seed market.